
Yih-horng Shiao
Examiner (ID: 7187, Phone: (571)272-7135 , Office: P/1672 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1672, 1623, 1673, 1691, 1621, 1693 |
| Total Applications | 1088 |
| Issued Applications | 699 |
| Pending Applications | 98 |
| Abandoned Applications | 306 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18947021
[patent_doc_number] => 11890294
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-06
[patent_title] => Skin barrier composition
[patent_app_type] => utility
[patent_app_number] => 17/500604
[patent_app_country] => US
[patent_app_date] => 2021-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 12
[patent_no_of_words] => 17545
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 225
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17500604
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/500604 | Skin barrier composition | Oct 12, 2021 | Issued |
Array
(
[id] => 17532358
[patent_doc_number] => 20220110967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => METHODS AND COMPOSITIONS FOR THERAPEUTIC SKIN TREATMENTS IN DERMATOLOGICAL PROCEDURES AFFECTING SKIN'S BARRIER
[patent_app_type] => utility
[patent_app_number] => 17/497436
[patent_app_country] => US
[patent_app_date] => 2021-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8417
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17497436
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/497436 | Methods and compositions for therapeutic skin treatments in dermatological procedures affecting skin's barrier | Oct 7, 2021 | Issued |
Array
(
[id] => 18786393
[patent_doc_number] => 20230374487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => IMPROVED REMOVAL OF RNA AND CONTAMINANTS FROM DNA PLASMID PREPARATIONS BY HYDROPHOBIC INTERACTION CHROMATOGRAPHY
[patent_app_type] => utility
[patent_app_number] => 18/029817
[patent_app_country] => US
[patent_app_date] => 2021-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4515
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18029817
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/029817 | IMPROVED REMOVAL OF RNA AND CONTAMINANTS FROM DNA PLASMID PREPARATIONS BY HYDROPHOBIC INTERACTION CHROMATOGRAPHY | Oct 4, 2021 | Pending |
Array
(
[id] => 17685809
[patent_doc_number] => 20220193101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => Methods for treating and Pharmaceutical compositions
[patent_app_type] => utility
[patent_app_number] => 17/494543
[patent_app_country] => US
[patent_app_date] => 2021-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11295
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17494543
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/494543 | Methods for treating and Pharmaceutical compositions | Oct 4, 2021 | Abandoned |
Array
(
[id] => 17458716
[patent_doc_number] => 20220072020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => ANTIMITOSCINS: TARGETED INHIBITORS OF MITOCHONDRIAL BIOGENESIS FOR ERADICATING CANCER STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/491672
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4237
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17491672
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/491672 | Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells | Sep 30, 2021 | Issued |
Array
(
[id] => 18754345
[patent_doc_number] => 20230357746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => BIOMOLECULE EXTRACTION METHOD
[patent_app_type] => utility
[patent_app_number] => 18/245743
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13591
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18245743
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/245743 | BIOMOLECULE EXTRACTION METHOD | Sep 16, 2021 | Pending |
Array
(
[id] => 17480542
[patent_doc_number] => 20220088046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => VIRAL RECEPTOR BOUND WITH SIALIC ACID COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/478185
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7883
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17478185
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/478185 | Viral receptor bound with sialic acid compounds | Sep 16, 2021 | Issued |
Array
(
[id] => 18962308
[patent_doc_number] => 11896043
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Intestinal immune-enhancing agent, food product, and medicament
[patent_app_type] => utility
[patent_app_number] => 17/476131
[patent_app_country] => US
[patent_app_date] => 2021-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 13027
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17476131
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/476131 | Intestinal immune-enhancing agent, food product, and medicament | Sep 14, 2021 | Issued |
Array
(
[id] => 17858516
[patent_doc_number] => 11439654
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-13
[patent_title] => Topical analgesic
[patent_app_type] => utility
[patent_app_number] => 17/467629
[patent_app_country] => US
[patent_app_date] => 2021-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22144
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17467629
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/467629 | Topical analgesic | Sep 6, 2021 | Issued |
Array
(
[id] => 18962303
[patent_doc_number] => 11896038
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Inhibited waxy starches and methods of using them
[patent_app_type] => utility
[patent_app_number] => 17/464519
[patent_app_country] => US
[patent_app_date] => 2021-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 12445
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17464519
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/464519 | Inhibited waxy starches and methods of using them | Aug 31, 2021 | Issued |
Array
(
[id] => 18709514
[patent_doc_number] => 20230332132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => RNA STORAGE METHOD
[patent_app_type] => utility
[patent_app_number] => 18/043254
[patent_app_country] => US
[patent_app_date] => 2021-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7406
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043254
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/043254 | RNA STORAGE METHOD | Aug 26, 2021 | Pending |
Array
(
[id] => 19423749
[patent_doc_number] => 12083140
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Pharmaceutical composition for preventing and treating glaucoma, containing adenosine derivative
[patent_app_type] => utility
[patent_app_number] => 17/458231
[patent_app_country] => US
[patent_app_date] => 2021-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 22
[patent_no_of_words] => 15881
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17458231
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/458231 | Pharmaceutical composition for preventing and treating glaucoma, containing adenosine derivative | Aug 25, 2021 | Issued |
Array
(
[id] => 17256769
[patent_doc_number] => 20210369754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => INHIBITOR OF SPHINGOSINE KINASE 2 FOR TREATING EBOLA
[patent_app_type] => utility
[patent_app_number] => 17/401950
[patent_app_country] => US
[patent_app_date] => 2021-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17401950
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/401950 | Inhibitor of sphingosine kinase 2 for treating Ebola | Aug 12, 2021 | Issued |
Array
(
[id] => 17503421
[patent_doc_number] => 20220096523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => COMPOSITIONS FOR THE TREATMENT OF DRY EYE
[patent_app_type] => utility
[patent_app_number] => 17/400815
[patent_app_country] => US
[patent_app_date] => 2021-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5401
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17400815
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/400815 | COMPOSITIONS FOR THE TREATMENT OF DRY EYE | Aug 11, 2021 | Abandoned |
Array
(
[id] => 18603455
[patent_doc_number] => 11744895
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-05
[patent_title] => Intranasal epinephrine formulations and methods for the treatment of disease
[patent_app_type] => utility
[patent_app_number] => 17/396044
[patent_app_country] => US
[patent_app_date] => 2021-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 33300
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17396044
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/396044 | Intranasal epinephrine formulations and methods for the treatment of disease | Aug 5, 2021 | Issued |
Array
(
[id] => 18707545
[patent_doc_number] => 20230330121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF BRONCHIOLITIS OBLITERANS
[patent_app_type] => utility
[patent_app_number] => 18/019322
[patent_app_country] => US
[patent_app_date] => 2021-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16220
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18019322
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/019322 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF BRONCHIOLITIS OBLITERANS | Aug 4, 2021 | Pending |
Array
(
[id] => 18675286
[patent_doc_number] => 20230312886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => BARRIER COMPOSITION, USE AND PRODUCTION METHOD THEREOF, STRUCTURES, USE AND PRODUCTION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/017928
[patent_app_country] => US
[patent_app_date] => 2021-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10154
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017928
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/017928 | BARRIER COMPOSITION, USE AND PRODUCTION METHOD THEREOF, STRUCTURES, USE AND PRODUCTION METHOD THEREOF | Jul 28, 2021 | Abandoned |
Array
(
[id] => 18923337
[patent_doc_number] => 20240026341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => PURIFICATION OF SULFONATED DNA
[patent_app_type] => utility
[patent_app_number] => 18/005943
[patent_app_country] => US
[patent_app_date] => 2021-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14971
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005943
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/005943 | PURIFICATION OF SULFONATED DNA | Jul 28, 2021 | Pending |
Array
(
[id] => 19291777
[patent_doc_number] => 12031125
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-09
[patent_title] => Method for isolating extracellular nucleic acids using anion exchange particles
[patent_app_type] => utility
[patent_app_number] => 17/385460
[patent_app_country] => US
[patent_app_date] => 2021-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 17775
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17385460
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/385460 | Method for isolating extracellular nucleic acids using anion exchange particles | Jul 25, 2021 | Issued |
Array
(
[id] => 17625863
[patent_doc_number] => 20220160878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => TOPIRAMATE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/384616
[patent_app_country] => US
[patent_app_date] => 2021-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9935
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17384616
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/384616 | Topiramate compositions and methods of making and using the same | Jul 22, 2021 | Issued |